Related Experiment Videos

[Vasodilator agents in portal hypertension]

J M Combis¹, J P Vinel

¹Service d'Hépato-Gastroentérologie, CHU Purpan, Toulouse.

Gastroenterologie Clinique Et Biologique

|January 1, 1991

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Influence of HCV genotype 1 subtypes on the virus response to PEG interferon alpha-2a plus ribavirin therapy.

Journal of medical virology·2011

Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease.

Alimentary pharmacology & therapeutics·2008

Management of failures of first line treatments.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2008

Fulminant liver failure from acute autochthonous hepatitis E in France: description of seven patients with acute hepatitis E and encephalopathy.

Journal of viral hepatitis·2007

KLF6 transcription factor protects hepatocellular carcinoma-derived cells from apoptosis.

Cell death and differentiation·2007

Treatment of experimental murine pancreatic peritoneal carcinomatosis with fibroblasts genetically modified to express IL12: a role for peritoneal innate immunity.

Gut·2006

See all related articles